Product image of Naratriptan Bei Migräne Heumann (Naratriptan) supplied by GNH India

Naratriptan Bei Migräne Heumann

Active Ingredient:
Naratriptan
Origin:
EU

Naratriptan Bei Migräne Heumann (Naratriptan)

Naratriptan, the active ingredient in Naratriptan Bei Migräne Heumann, is a Triptan (5‑HT1B/1D receptor agonist) presented as a tablet for oral use. It is employed for the acute treatment of migraine attacks in adult patients, providing rapid relief of headache and associated symptoms.

GNH India supplies Naratriptan Bei Migräne Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics and comprehensive documentation for import compliance.

Manufacturer / TM Owner

Heumann Pharma Gmbh & Co. Generica Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naratriptan is a selective serotonin 5‑HT1B/1D receptor agonist used in the acute treatment of migraine.

  • Migraine: reduces headache intensity and associated nausea, photophobia, and phonophobia during an acute attack.
  • Migraine with aura: alleviates pain and visual disturbances when administered early in the attack.
  • Migraine without aura: provides rapid relief of headache and related symptoms in patients lacking aura.

How It Works

  • Naratriptan binds selectively to serotonin 5‑HT1B and 5‑HT1D receptors located on intracranial blood vessels and trigeminal nerve endings. Activation of 5‑HT1B receptors induces cranial vasoconstriction, while stimulation of 5‑HT1D receptors inhibits release of pro‑inflammatory neuropeptides. Together these actions suppress the trigeminovascular pathway, decreasing pain transmission and relieving migraine symptoms. The drug’s high affinity for these receptor subtypes ensures a targeted effect with minimal impact on peripheral serotonergic systems.

Side Effects

Naratriptan may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate feeling of stomach upset.
  • Dizziness: transient light‑headedness or vertigo.
  • Fatigue: feeling of tiredness or reduced energy.
  • Dry mouth: reduced salivation causing throat discomfort.

Serious or Rare Side Effects

  • Chest pain: possible indication of cardiac ischemia.
  • Serotonin syndrome: agitation, hyperthermia, muscle rigidity in combination with other serotonergic agents.
  • Severe hypertension: sudden increase in blood pressure requiring medical attention.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.

Precautions & Warnings

Before prescribing Naratriptan, clinicians should evaluate several safety considerations to minimize risk.

  • Cardiovascular assessment: review history of coronary artery disease, stroke, or uncontrolled hypertension.
  • Concomitant serotonergic drugs: avoid use with SSRIs, SNRIs, MAO inhibitors, or other triptans due to serotonin syndrome risk.
  • Age restrictions: not recommended for children or adolescents under 18 years of age.
  • Pregnancy and lactation: use only if potential benefit justifies potential risk; limited data available.
  • Drug interactions: assess for potential major interactions listed in prescribing information.
  • Store at ambient temperature: keep tablets in original container, protect from moisture and heat.

Avoid Interactions

Naratriptan can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • MAO inhibitors: risk of severe hypertension and serotonin syndrome.
  • SSRIs, SNRIs, or other serotonergic agents: increased chance of serotonin syndrome.
  • Ergot derivatives: additive vasoconstrictive effects may cause coronary spasm.
  • Other triptans: combined use can lead to excessive vasoconstriction.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: may reduce blood pressure control.
  • Oral contraceptives: possible alteration of plasma levels.
  • Antihistamines: may increase sedation or dizziness.
  • CYP1A2 inhibitors: could raise naratriptan concentrations.

Frequently Asked Questions

Naratriptan is prescribed for the acute treatment of migraine attacks in adults. It helps to relieve headache pain and associated symptoms such as nausea, sensitivity to light, and sound when taken at the onset of an attack.

Naratriptan works by selectively activating serotonin 5‑HT1B and 5‑HT1D receptors in the brain. This causes constriction of dilated cranial blood vessels and blocks the release of pain‑triggering neuropeptides, thereby interrupting the migraine pain pathway.

The dosage of Naratriptan is determined by the prescribing clinician based on the patient’s condition, response, and any relevant medical history. The prescriber will select the appropriate tablet strength and timing for each individual.

Safety data for Naratriptan in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naratriptan belongs to the triptan class, similar to sumatriptan and rizatriptan. Compared with some alternatives, it has a longer half‑life, which may provide extended relief for prolonged attacks, while maintaining a comparable safety profile when used as directed.

Store Naratriptan tablets at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect from moisture and direct heat, and keep out of reach of children.

Naratriptan is taken orally as a tablet with a glass of water. It is usually taken as soon as migraine symptoms begin, and may be repeated after a prescribed interval if needed, following the prescriber’s instructions.

Serious risks include chest pain or pressure that could signal cardiac ischemia, serotonin syndrome when combined with other serotonergic drugs, severe hypertension, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if any of these occur.

Naratriptan is contraindicated in patients with a history of coronary artery disease, uncontrolled hypertension, cerebrovascular disease, peripheral vascular disease, or known hypersensitivity to the drug. It should also be avoided in individuals taking MAO inhibitors or other triptans.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naratriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT